KNT-0916

· KinoTeck Therapeutics Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KNT-0916, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 Alterations [Phase 1]